Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Folivane-F is a prescription-strength prenatal vitamin and mineral supplement developed by Trigen Laboratories. It is formulated to provide essential nutrients to women during pregnancy and lactation, as well as to manage iron deficiency anemia. The supplement typically contains a combination of carbonyl iron, folic acid, and various vitamins (B6, B12, C, D3, E) and minerals (zinc, copper, magnesium). Carbonyl iron serves as a source of elemental iron to support hemoglobin production, while folic acid is critical for preventing neural tube defects and supporting fetal development. As a prescription dietary supplement, it is intended for use under medical supervision to ensure adequate nutritional intake in populations with increased metabolic demands or malabsorption.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Folivane-F.